Skip to main content

Table 2 Medication and resource use by children in foster care compared to those receiving Medicaid

From: High-level psychotropic polypharmacy: a retrospective comparison of children in foster care to their peers on Medicaid

  Children with High-Level Polypharmacy  
  Foster Care Medicaida p
Number of children 417 1823  
bPychotropic duration (days) 344.00 [315.00, 358.00] 349.00 [326.00, 358.00] 0.004
cPolypharmacy duration (days) 325.00 [278.00, 345.00] 330.00 [289.00, 346.00] 0.104
dPolypharmacy duration (days) 144.00 [67.00, 244.00] 156.00 [78.00, 255.00] 0.119
eAPM duration (days) 285.00 [185.00, 333.00] 281.00 [181.00, 326.00] 0.193
Utilization Measures
fMetabolic Screen (%)    < 0.001
 No screen 248 (59.5) 1328 (72.8)  
 1 screen 138 (33.1) 426 (23.4)  
 2 screens 25 (6.0) 64 (3.5)  
 3 screens 6 (1.4) 5 (0.3)  
 Emergency Department Visits 2.39 (3.6) 1.72 (3.1) < 0.001
 Outpatient Visits (mean (SD)) 11.09 (9.6) 14.35 (20.0) 0.001
 Inpatient Visits (mean (SD)) 0.81 (1.4) 0.36 (0.9) < 0.001
  1. Note. IQR Intra-quartile range
  2. aChildren receiving Medicaid services who are not in foster care; bat least 1 psychotropic medication (median [IQR]); cat least 2 psychotropic medications (median [IQR]); dat least 4 psychotropic medications (median [IQR]); eat least 1 antipsychotic medication (median [IQR]); fMetabolic screening = presence of both lipid and glucose lab testing, as indicated by CPT codes